4//SEC Filing
Epizyme, Inc. 4
Accession 0001209191-17-031492
CIK 0001571498operating
Filed
May 10, 8:00 PM ET
Accepted
May 11, 2:27 PM ET
Size
11.3 KB
Accession
0001209191-17-031492
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Singer Andrew E.
EVP & CFO
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001
2017-05-09+1,682→ 40,316 total - Exercise/Conversion
Common Stock, par value $0.0001
2017-05-09+778→ 41,094 total - Exercise/Conversion
Restricted Stock Units
2017-05-09−1,682→ 35,320 total→ Common Stock (1,682 underlying) - Exercise/Conversion
Restricted Stock Units
2017-05-09−778→ 16,324 total→ Common Stock (778 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents the contingent right to receive one share of Epizyme, Inc. common stock upon vesting.
- [F2]This award, granted on February 9, 2016, pursuant to the Company's 2013 Stock Incentive plan, vests as to 25% of the total award on February 9, 2016, a year from the commencement of employment, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.
- [F3]This award, granted on February 9, 2015, pursuant to the Company's 2013 Stock Inventive Plan, vests as to 25% of the total award on February 9, 2016, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.
Documents
Issuer
Epizyme, Inc.
CIK 0001571498
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001571498
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 2:27 PM ET
- Size
- 11.3 KB